526 related articles for article (PubMed ID: 17561242)
1. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
González-Rioja R; Ibarrola I; Arilla MC; Ferrer A; Mir A; Andreu C; Martínez A; Asturias JA
J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
[TBL] [Abstract][Full Text] [Related]
2. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
Rossi RE; Monasterolo G; Coco G; Operti D
Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Parietaria judaica pollen allergy using natural and recombinant Par j 1 and Par j 2 allergens.
González-Rioja R; Ferrer A; Arilla MC; Ibarrola I; Viguera AR; Andreu C; Martínez A; Asturias JA
Clin Exp Allergy; 2007 Feb; 37(2):243-50. PubMed ID: 17250697
[TBL] [Abstract][Full Text] [Related]
4. A hybrid expressing genetically engineered major allergens of the Parietaria pollen as a tool for specific allergy vaccination.
Bonura A; Corinti S; Artale A; Di Felice G; Amoroso S; Melis M; Geraci D; Colombo P
Int Arch Allergy Immunol; 2007; 142(4):274-84. PubMed ID: 17124429
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a Par j 1/Par j 2 mutant hybrid with reduced allergenicity for immunotherapy of Parietaria allergy.
Bonura A; Passantino R; Costa MA; Montana G; Melis M; Bondì ML; Butteroni C; Barletta B; Corinti S; Di Felice G; Colombo P
Clin Exp Allergy; 2012 Mar; 42(3):471-80. PubMed ID: 22356145
[TBL] [Abstract][Full Text] [Related]
6. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
7. "Allergen engineering": variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity.
Schramm G; Kahlert H; Suck R; Weber B; Stüwe HT; Müller WD; Bufe A; Becker WM; Schlaak MW; Jäger L; Cromwell O; Fiebig H
J Immunol; 1999 Feb; 162(4):2406-14. PubMed ID: 9973522
[TBL] [Abstract][Full Text] [Related]
8. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of sensitization to Artemisia allergens Art v 1, Art v 3 and Art v 60 kDa. Cross-reactivity among Art v 3 and other relevant lipid-transfer protein allergens.
Lombardero M; García-Sellés FJ; Polo F; Jimeno L; Chamorro MJ; García-Casado G; Sánchez-Monge R; Díaz-Perales A; Salcedo G; Barber D
Clin Exp Allergy; 2004 Sep; 34(9):1415-21. PubMed ID: 15347375
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
García Villalmanzo I; Hernández MD; Campos A; Giner AM; Polo F; Cortés C; Basomba A
J Investig Allergol Clin Immunol; 1999; 9(5):321-9. PubMed ID: 10582201
[TBL] [Abstract][Full Text] [Related]
11. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
[TBL] [Abstract][Full Text] [Related]
12. Generation of a low immunoglobulin E-binding mutant of the timothy grass pollen major allergen Phl p 5a.
Wald M; Kahlert H; Weber B; Jankovic M; Keller W; Cromwell O; Nandy A; Fiebig H
Clin Exp Allergy; 2007 Mar; 37(3):441-50. PubMed ID: 17359394
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.
Hirahara K; Tatsuta T; Takatori T; Ohtsuki M; Kirinaka H; Kawaguchi J; Serizawa N; Taniguchi Y; Saito S; Sakaguchi M; Inouye S; Shiraishi A
J Allergy Clin Immunol; 2001 Jul; 108(1):94-100. PubMed ID: 11447388
[TBL] [Abstract][Full Text] [Related]
15. Assignment of disulphide bridges in Par j 2.0101, a major allergen of Parietaria judaica pollen.
Amoresano A; Pucci P; Duro G; Colombo P; Costa MA; Izzo V; Lamba D; Geraci D
Biol Chem; 2003 Aug; 384(8):1165-72. PubMed ID: 12974385
[TBL] [Abstract][Full Text] [Related]
16. Isolation, expression and immunological characterization of a calcium-binding protein from Parietaria pollen.
Bonura A; Gulino L; Trapani A; Di Felice G; Tinghino R; Amoroso S; Geraci D; Valenta R; Westritschnig K; Scala E; Mari A; Colombo P
Mol Immunol; 2008 May; 45(9):2465-73. PubMed ID: 18289680
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cross-reactivity between Holoptelea integrifolia and Parietaria judaica.
Sharma S; Panzani RC; Gaur SN; Ariano R; Singh AB
Int Arch Allergy Immunol; 2005 Feb; 136(2):103-12. PubMed ID: 15650307
[TBL] [Abstract][Full Text] [Related]
18. [Specific skin reactions induced by individual pollen preparations in hypersensitivity persons].
Paranos S; Petrović S; Vojović I
Srp Arh Celok Lek; 1998; 126(9-10):362-7. PubMed ID: 9863408
[TBL] [Abstract][Full Text] [Related]
19. Allergenicity and cross-reactivity of Senecio pollen: identification of novel allergens using the immunoproteomics approach.
Luengo O; Mollá R; Gámez C; Cardona V; López E; Sastre B; Waisel Y; Belmonte J; Cadahia A; Lahoz C; del Pozo V
Clin Exp Allergy; 2008 Jun; 38(6):1048-60. PubMed ID: 18489028
[TBL] [Abstract][Full Text] [Related]
20. Constructing a hybrid molecule with low capacity of IgE binding from Chenopodium album pollen allergens.
Nouri HR; Varasteh A; Vahedi F; Chamani J; Afsharzadeh D; Sankian M
Immunol Lett; 2012 May; 144(1-2):67-77. PubMed ID: 22504204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
